BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7525057)

  • 41. Identification and characterization of a rat protein (p 105) auto-antigenic in rats bearing a progressive syngeneic colon carcinoma.
    Blottière HM; Menoret A; Burg C; Douillard JY; Le Pendu J
    Int J Cancer; 1992 Jan; 50(2):315-20. PubMed ID: 1730526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The expression of carbohydrate blood group antigens correlates with heat resistance.
    Ménoret A; Otry C; Labarrière N; Breimer ME; Piller F; Meflah K; Le Pendu J
    J Cell Sci; 1995 Apr; 108 ( Pt 4)():1691-701. PubMed ID: 7615686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ABH blood group antigens on cultured epithelial cells.
    Phillips S; Miller OJ; Kabat EA
    Birth Defects Orig Artic Ser; 1980; 16(2):339-44. PubMed ID: 7213973
    [No Abstract]   [Full Text] [Related]  

  • 44. [Enhanced metastatic potential of rat RG2 glioblastoma cells transfected with CD44v (meta-1) sequence].
    Li H; Hofmann M; Liu J
    Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):343-6. PubMed ID: 9387271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in ABH antigen expression on red cells during in vivo aging: a flow cytometric analysis.
    Fibach E; Sharon R
    Transfusion; 1994 Apr; 34(4):328-32. PubMed ID: 7513908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating free methylglyoxal as a metabolic tumor biomarker in a rat colon adenocarcinoma model.
    Irigaray P; Belpomme D
    Mol Clin Oncol; 2020 Apr; 12(4):311-316. PubMed ID: 32190311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. (Sialyl)Lewis Antigen Expression on Glycosphingolipids, N-, and O-Glycans in Colorectal Cancer Cell Lines is Linked to a Colon-Like Differentiation Program.
    Wang D; Madunić K; Mayboroda OA; Lageveen-Kammeijer GSM; Wuhrer M
    Mol Cell Proteomics; 2024 Jun; 23(6):100776. PubMed ID: 38670309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Prognostic Impact of ABO Blood Group in Hepatocellular Carcinoma Following Hepatectomy.
    Kaibori M; Yoshii K; Matsui K; Matsushima H; Kosaka H; Yamamoto H; Nakajima T; Aoi K; Yamaguchi T; Yoshida K; Sekimoto M
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD44 Glycosylation as a Therapeutic Target in Oncology.
    Liao C; Wang Q; An J; Chen J; Li X; Long Q; Xiao L; Guan X; Liu J
    Front Oncol; 2022; 12():883831. PubMed ID: 35936713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.
    Huang JY; Wang R; Gao YT; Yuan JM
    PLoS One; 2017; 12(9):e0184295. PubMed ID: 28880901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fucosylation of LAMP-1 and LAMP-2 by FUT1 correlates with lysosomal positioning and autophagic flux of breast cancer cells.
    Tan KP; Ho MY; Cho HC; Yu J; Hung JT; Yu AL
    Cell Death Dis; 2016 Aug; 7(8):e2347. PubMed ID: 27560716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel role for inducible Fut2 in angiogenesis.
    Tsou PS; Ruth JH; Campbell PL; Isozaki T; Lee S; Marotte H; Domino SE; Koch AE; Amin MA
    Angiogenesis; 2013 Jan; 16(1):195-205. PubMed ID: 23065099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse model.
    Ozaki H; Matsuzaki H; Ando H; Kaji H; Nakanishi H; Ikehara Y; Narimatsu H
    Clin Exp Metastasis; 2012 Mar; 29(3):229-38. PubMed ID: 22228572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I.
    Gao L; Yan L; Lin B; Gao J; Liang X; Wang Y; Liu J; Zhang S; Iwamori M
    J Exp Clin Cancer Res; 2011 Feb; 30(1):15. PubMed ID: 21294926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lewis Y promotes growth and adhesion of ovarian carcinoma-derived RMG-I cells by upregulating growth factors.
    Li F; Lin B; Hao Y; Li Y; Liu J; Cong J; Zhu L; Liu Q; Zhang S
    Int J Mol Sci; 2010 Sep; 11(10):3748-59. PubMed ID: 21152298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel clinically relevant animal model for studying galectin-3 and its ligands during colon carcinogenesis.
    Hill M; Mazal D; Biron VA; Pereira L; Ubillos L; Berriel E; Ahmed H; Freire T; Rondán M; Vasta GR; Liu FT; Iglesias MM; Osinaga E
    J Histochem Cytochem; 2010 Jun; 58(6):553-65. PubMed ID: 20197492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell surface fucosylation does not affect development of colon tumors in mice with germline Smad3 mutation.
    Domino SE; Karnak DM; Hurd EA
    Tumour Biol; 2007; 28(2):77-83. PubMed ID: 17264540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer.
    Masson D; Denis MG; Denis M; Blanchard D; Loirat MJ; Cassagnau E; Lustenberger P
    Br J Cancer; 1999 Aug; 80(12):1995-2000. PubMed ID: 10471052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The normal structure and function of CD44 and its role in neoplasia.
    Sneath RJ; Mangham DC
    Mol Pathol; 1998 Aug; 51(4):191-200. PubMed ID: 9893744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Forms and functions of CD44.
    Borland G; Ross JA; Guy K
    Immunology; 1998 Feb; 93(2):139-48. PubMed ID: 9616361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.